Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06720415 · ClinicalTrials.gov registry record · Phase 4
Oral and Intravenous Methadone for Analgesia in Cardiac Surgery
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 41
- Enrollment target
NCT06720415: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT06720415 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 41 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06720415, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effects of administration of oral methadone preoperatively and intravenous methadone upon induction of general anesthesia on postoperative pain for patients undergoing elective cardiac surgery.
Primary Outcome
Oral morphine milligram equivalents
Interventions
- DRUG Oral methadone, immediately prior to transport
- DRUG Intravenous methadone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2025-04-14 |
| Est. Completion | 2025-07-14 |
| Phase | Phase 4 |
What the finished NCT06720415 record still lists
NCT06720415 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Oral methadone, immediately prior to transport is the first listed.
NCT06720415 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06720415 about?
NCT06720415 is a clinical study titled "Oral and Intravenous Methadone for Analgesia in Cardiac Surgery". The purpose of this study is to compare the effects of administration of oral methadone preoperatively and intravenous methadone upon induction of general anesthesia on postoperative pain for patients undergoing elective cardiac surgery.
What is the current status of trial NCT06720415?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 41 participants. The study started on 2025-04-14. Estimated completion is 2025-07-14.
What interventions are being tested in trial NCT06720415?
The interventions under investigation include: Oral methadone, immediately prior to transport (DRUG), Intravenous methadone (DRUG).
Who is sponsoring clinical trial NCT06720415?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06720415's enrollment target sits among peer trials
41 1390th of 2000 higher than 604 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI